Dexmedetomidine clinical trials

Explore recruiting dexmedetomidine clinical trials.

Recruiting dexmedetomidine studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dexmedetomidine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The use of intranasal dexmedetomidine for pediatric sedation in non-invasive radiological procedures (CTMS 004321) Assessing the efficacy and safety profile of intranasal dexmedetomidine for procedural sedation in radiological procedures in children with a prospective exploratory interventional monocentric study in a tertiary center in Antwerp (Belgium)

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

OFA-VATS : Impact of opioid free anesthesia on postoperative quality of recovery and analgesia after video or robot assisted thoracic surgery

France

Phase III and phase IV (Integrated) EU CTIS Study details

ADRESS : Efficacy of the Alpha 2 agonist dexmedetomidine for sympathetic Deactivation in REfractory Septic Shock: a randomized, controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intranasal dexmedetomidine sedation and analgesia during minor procedures in the pediatric emergency room: Randomized double-blinded clinical trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Comparison of different doses of perineural dexmedetomidine as adjuvans to ropivacaine 0,67% for interscalene plexus block in association with 10 mg intravenous dexamethasone: a single center, double blinded, randomised controlled trial.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Comparison of different doses of perineural dexmedetomidine as adjuvans to ropivacaine 0,67% for interscalene plexus block in association with 10 mg intravenous dexamethasone: a single center, double blinded, randomised controlled trial.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Dexmedetomidine trials by city

Dexmedetomidine in Toronto Dexmedetomidine in Vancouver Dexmedetomidine in Montreal Dexmedetomidine in Calgary Dexmedetomidine in Edmonton Dexmedetomidine in Ottawa Dexmedetomidine in Winnipeg Dexmedetomidine in Quebec City Dexmedetomidine in Hamilton Dexmedetomidine in Kitchener Dexmedetomidine in London Dexmedetomidine in Halifax Dexmedetomidine in New York Dexmedetomidine in Los Angeles Dexmedetomidine in Chicago Dexmedetomidine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease